NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer VA Belle, N McDermott, A Meunier, L Marignol Nature Reviews Urology 11 (9), 499-507, 2014 | 110 | 2014 |
Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells N McDermott, A Meunier, B Mooney, G Nortey, C Hernandez, S Hurley, ... Scientific reports 6 (1), 34796, 2016 | 51 | 2016 |
Isogenic radiation resistant cell lines: development and validation strategies N McDermott, A Meunier, TH Lynch, D Hollywood, L Marignol International journal of radiation biology 90 (2), 115-126, 2014 | 29 | 2014 |
Profiling of a panel of radioresistant prostate cancer cells identifies deregulation of key miRNAs N McDermott, A Meunier, S Wong, V Buchete, L Marignol Clinical and Translational Radiation Oncology 2, 63-68, 2017 | 25 | 2017 |
The Notch-3 receptor: A molecular switch to tumorigenesis? S Inder, S O'Rourke, N McDermott, R Manecksha, S Finn, T Lynch, ... Cancer Treatment Reviews 60, 69-76, 2017 | 16 | 2017 |
YB-1: The key to personalised prostate cancer management? M Bates, A Boland, N McDermott, L Marignol Cancer letters 490, 66-75, 2020 | 15 | 2020 |
Hypoxia regulates Notch-3 mRNA and receptor activation in prostate cancer cells A Meunier, VA Belle, N McDermott, K Rivera-Figueroa, A Perry, T Lynch, ... Heliyon 2 (5), 2016 | 11 | 2016 |
Multiplex profiling identifies clinically relevant signalling proteins in an isogenic prostate cancer model of radioresistance S Inder, M Bates, N Ni Labhrai, N McDermott, J Schneider, G Erdmann, ... Scientific Reports 9 (1), 17325, 2019 | 10 | 2019 |
Capitalizing on cancer replication stress by preventing par chain turnover: A new type of synthetic lethality N McDermott, ES Buechelmaier, SN Powell Cancer cell 35 (3), 344-346, 2019 | 8 | 2019 |
Identification of suitable endogenous controls for gene and miRNA expression studies in irradiated prostate cancer cells H Lawlor, A Meunier, N McDermott, TH Lynch, L Marignol Tumor Biology 36, 6019-6028, 2015 | 8 | 2015 |